valuating drugs is easy; assessing the healthfulness of food is not. For drugs, we have a proscribed process: determine the dose; screen for toxicity; and then randomly give the drug or its placebo to enough subjects for a sufficient length of time to acquire statistically meaningful endpoints. Deciphering good nutrition is far more complex. As omnivores, our food choices are endless.
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We select food by habit, taste, cost, and availability.
Food healthfulness trails these selection factors and is generally poorly understood, even by the medical community. On average, medical students receive only 23.9 h of instruction on nutrition (1). Drugs come ready to take; food needs preparation. Unfortunately, this task is increasingly done for us by the food industry. Unlike Pharma, the food industry is not required to assess healthfulness. Cooking techniques matter. Baked and broiled fish reduce the incidence of heart failure; fried fish does the opposite (2).
As with drugs, food combinations affect their biological impact. Endothelial function is decreased by olive oil alone, but not when consumed on a salad (3). Evaluating food requires long-term studies because diseases such as atherosclerosis take years to decades to become manifest. Unlike drug trials, food trials cannot be blinded, and adherence to an experimental diet is often problematic. Importantly, removal of a food or macronutrient from a diet to assess its potential harm requires adding back some other food to maintain energy intake. Without certainty of the healthfulness of the substituted food, such an assessment is meaningless.
Although factually correct, last year's metaanalysis showing a neutral effect of dietary saturated fatty acids (SFA) on coronary heart disease (CHD) lacked insight into food substitution (4). Adding to the public's confusion, a responding Time magazine cover story was headlined "Eat Butter.
Scientists labeled fat the enemy. Why they were wrong" (5). In this issue of the Journal, Li et al. Nutrition science is slowly realizing the adverse cardiovascular effects of refined starches and added sugars. In a National Health and Nutrition Examination Survey study of 11,733 healthy subjects, daily consumption of >25% of energy intake from added sugar was associated with an almost 3-fold increase in cardiovascular disease mortality compared with that of subjects with <10% added sugar intake (10). Three 12-oz cans of most regular soft drinks provide >25% of daily energy intake from added sugar.
A meta-analysis of 39 dietary trials recently showed that a high intake of added sugar is associated with increased low-density lipoprotein cholesterol, triglycerides, and blood pressure, the latter by 7/6 mm Hg (11) .
One important limitation of the current study is is an important factor in hepatic conversion to glucose versus triglycerides. Clearly, fruit is more than fructose, and its fiber and micronutrients make a difference. Our current understanding of nutrition is not sufficient to assign benefit to the specific micronutrients that make fruits and vegetables so healthful.
Alcohol, a simple sugar, was also excluded because of its widely recognized association with reduced CHD, especially as consumed in the Mediterranean diet.
Lastly, even the most detailed, self-reported diet questionnaire is never as accurate as a good pill count.
What we are left with is a slightly clearer message about food as heart medicine. We in health care need to be better informed about nutrition and nutritional research and have a clearer public health message.
The challenge will be to convince an increasingly wary public that we know what we are talking about.
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